Buy or sell Symbiont stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Symbiont Stock

Symbiont has developed the market-leading platform for institutional applications of blockchain technology.

Founded

2015

Notable Investors

Wicklow Capital

Headquarters

New York NY, US

Total Funding

$15.4M

About Symbiont Stock

Symbiont has developed the market-leading platform for institutional applications of blockchain technology. Symbiont smart contracts enable complex instruments to live their entire lifecycle on a truly decentralized, enterprise blockchain network with end-to-end privacy. Financial institutions and governments are working with Symbiont to develop new business lines, increase transparency, reduce risk, and save costs. Industry leaders such as Vanguard and the State of Delaware have chosen to partner with Symbiont. Headquartered in New York City, Symbiont is a financial technology company founded by a team of experts in capital markets and blockchain technology.

Investors

Funding History

June 2014$375K
May 2017$15.0M

Management

Founder

Evan Wagner

Founder & CEO

Mark Smith

Founder & Chief Technology Officer

Adam Krellenstein

Chairman & President

Caitlin Long

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Symbiont or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 140K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo